Silvercrest Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Silvercrest Asset Management's RGEN Position: Q2 2026 in Review
Silvercrest Asset Management increased its Repligen (RGEN) stake by 241% in Q2 2026, buying an estimated $25.2M and bringing the position to 290,559 shares worth $39.6M. The position accounts for 0.26% of the portfolio, ranked #97.
Silvercrest Asset Management first reported a position in RGEN in Q2 2023 and has held it in 7 quarters since. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Silvercrest Asset Management held 290,559 shares of Repligen worth $39.6M as of Q2 2026.
- Silvercrest Asset Management bought 205,452 Repligen shares in Q2 2026, an estimated $25.2M.
- Repligen made up 0.26% of Silvercrest Asset Management's portfolio in Q2 2026, its #97 holding.
- Silvercrest Asset Management first reported a position in Repligen in Q2 2023 and has held it in 7 quarters since.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.